JP2024544975A5 - - Google Patents
Info
- Publication number
- JP2024544975A5 JP2024544975A5 JP2024527868A JP2024527868A JP2024544975A5 JP 2024544975 A5 JP2024544975 A5 JP 2024544975A5 JP 2024527868 A JP2024527868 A JP 2024527868A JP 2024527868 A JP2024527868 A JP 2024527868A JP 2024544975 A5 JP2024544975 A5 JP 2024544975A5
- Authority
- JP
- Japan
- Prior art keywords
- unsubstituted
- substituted
- independently
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163279269P | 2021-11-15 | 2021-11-15 | |
| US63/279,269 | 2021-11-15 | ||
| PCT/US2022/079788 WO2023086978A2 (en) | 2021-11-15 | 2022-11-14 | Branched triple lipid-modified nucleic acid compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544975A JP2024544975A (ja) | 2024-12-05 |
| JP2024544975A5 true JP2024544975A5 (cg-RX-API-DMAC10.html) | 2025-11-28 |
Family
ID=86336679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024527868A Pending JP2024544975A (ja) | 2021-11-15 | 2022-11-14 | 分岐した三重脂質修飾核酸化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250215432A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4433063A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024544975A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240101658A9 (cg-RX-API-DMAC10.html) |
| CN (1) | CN118215485A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022388810A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3235963A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL312510A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024005863A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023086978A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026163078A1 (en) | 2025-01-29 | 2026-08-06 | Novartis Ag | Compounds targeting dmpk for the treatment of myotonic dystrophy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014205451A2 (en) * | 2013-06-21 | 2014-12-24 | Isis Pharmaceuticals, Inc. | Compositions and methods for modulation of target nucleic acids |
| EP3603648B1 (en) * | 2017-03-29 | 2025-09-17 | Shionogi & Co., Ltd | Complex of nucleic acid medicine and multibranched lipid |
| JP7583712B2 (ja) * | 2018-05-30 | 2024-11-14 | ノバルティス アーゲー | 脂質修飾された核酸化合物および方法 |
| JP2023503644A (ja) * | 2019-11-27 | 2023-01-31 | ディー・ティー・エックス・ファーマ・インコーポレイテッド | デュシェンヌ型筋ジストロフィーの治療のための化合物および方法 |
-
2022
- 2022-11-14 CA CA3235963A patent/CA3235963A1/en active Pending
- 2022-11-14 IL IL312510A patent/IL312510A/en unknown
- 2022-11-14 JP JP2024527868A patent/JP2024544975A/ja active Pending
- 2022-11-14 US US18/708,780 patent/US20250215432A1/en active Pending
- 2022-11-14 WO PCT/US2022/079788 patent/WO2023086978A2/en not_active Ceased
- 2022-11-14 AU AU2022388810A patent/AU2022388810A1/en active Pending
- 2022-11-14 MX MX2024005863A patent/MX2024005863A/es unknown
- 2022-11-14 EP EP22893902.1A patent/EP4433063A4/en active Pending
- 2022-11-14 KR KR1020247019228A patent/KR20240101658A9/ko active Pending
- 2022-11-14 CN CN202280074513.XA patent/CN118215485A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021201075B2 (en) | Novel lipids and compositions for the delivery of therapeutics | |
| CN110072530B (zh) | 4′-磷酸酯类似物和包含其的寡核苷酸 | |
| JP7748500B2 (ja) | トリループを含む二本鎖核酸インヒビター分子 | |
| US7053199B2 (en) | Nucleoside analogs and oligonucleotide derivatives containing these analogs | |
| JP2023503722A5 (cg-RX-API-DMAC10.html) | ||
| JP2023503644A5 (cg-RX-API-DMAC10.html) | ||
| US6066447A (en) | Modified oligonucleotides | |
| TW202122093A (zh) | 化合物、藥物綴合物、試劑盒及其用途 | |
| JPH08511002A (ja) | ポリヌクレオチド架橋剤としての非ヌクレオシドクマリン誘導体 | |
| CN1681814A (zh) | 通过1h-咪唑并[4,5-c]喹啉-4-邻苯二甲酰亚胺类中间体制备1h-咪唑并[4,5-c]喹啉-4-胺类化合物 | |
| JP2008048741A (ja) | 新規な塩基対形成スキームの使用による非特異的ハイブリダイゼーションの減少 | |
| EP0688784A2 (de) | Neue 3'-Modifizierte Oligonucleotid-Derivate | |
| JPH05505101A (ja) | オリゴヌクレオチド療法における三重らせん形成 | |
| JP2004537517A5 (cg-RX-API-DMAC10.html) | ||
| JP2005519035A5 (cg-RX-API-DMAC10.html) | ||
| JP2025038097A (ja) | 核酸、薬物組成物及び複合体ならびに調製方法と使用 | |
| JP2024536146A5 (cg-RX-API-DMAC10.html) | ||
| JP2024543372A5 (cg-RX-API-DMAC10.html) | ||
| CA3094008A1 (en) | Double-stranded nucleic acid inhibitor molecules modified with tm-increasing nucleotides | |
| JP2025511183A5 (cg-RX-API-DMAC10.html) | ||
| EP1142902A2 (de) | 3'-Derivatisierte Oligonucleotidanaloga mit nichtnucleotidischen Gruppierungen, deren Herstellung und Verwendung | |
| JPWO2023032995A5 (cg-RX-API-DMAC10.html) | ||
| JP7854977B2 (ja) | 分子の膜貫通送達のための化合物および方法 | |
| US20110130557A1 (en) | Intercalating triplexes and duplexes using aryl naphthoimidazol and process for the preparation thereof | |
| DE60225652T2 (de) | Oligonukleotidmarkierungsreagenzien auf der Basis von azyklischen Nukleosiden, und deren derivatisierte Konjugate |